These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23293208)

  • 1. Severe hepatitis induced by cyproterone acetate: role of corticosteroids. A case report.
    Abenavoli L; Milic N; Beaugrand M
    Ann Hepatol; 2013; 12(1):152-5. PubMed ID: 23293208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute hepatitis induced by cyproterone acetate.
    Giordano N; Nardi P; Santacroce C; Geraci S; Gennari C
    Ann Pharmacother; 2001 Sep; 35(9):1053-5. PubMed ID: 11573856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suspected cross-hepatotoxicity of flutamide and cyproterone acetate.
    Miquel M; Soler A; Vaqué A; Ojanguren I; Costa J; Planas R
    Liver Int; 2007 Oct; 27(8):1144-7. PubMed ID: 17845544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiandrogen-associated hepatotoxicity in the management of advanced prostate cancer.
    Lin AD; Chen KK; Lin AT; Chang YH; Wu HH; Kuo JY; Huang WJ; Hsu YS; Chung HJ; Chang LS
    J Chin Med Assoc; 2003 Dec; 66(12):735-40. PubMed ID: 15015823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyproterone acetate induces a wide spectrum of acute liver damage including corticosteroid-responsive hepatitis: report of 22 cases.
    Bessone F; Lucena MI; Roma MG; Stephens C; Medina-Cáliz I; Frider B; Tsariktsian G; Hernández N; Bruguera M; Gualano G; Fassio E; Montero J; Reggiardo MV; Ferretti S; Colombato L; Tanno F; Ferrer J; Zeno L; Tanno H; Andrade RJ
    Liver Int; 2016 Feb; 36(2):302-10. PubMed ID: 26104271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe hepatocellular dysfunction following cyproterone acetate therapy.
    Parys BT; Hamid S; Thomson RG
    Br J Urol; 1991 Mar; 67(3):312-3. PubMed ID: 1827039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatal fulminant hepatic failure due to cyproterone acetate.
    Friedman G; Lamoureux E; Sherker AH
    Dig Dis Sci; 1999 Jul; 44(7):1362-3. PubMed ID: 10489919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute hepatic necrosis in a patient treated with cyproterone acetate].
    Lombardi A; Ferrazza P; Castaldi F; Covotta L; Tesoriere A; Urbano V; Midiri G
    G Chir; 1998 Apr; 19(4):161-3. PubMed ID: 9628065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatotoxicity induced by cyproterone acetate: a report of three cases.
    Savidou I; Deutsch M; Soultati AS; Koudouras D; Kafiri G; Dourakis SP
    World J Gastroenterol; 2006 Dec; 12(46):7551-5. PubMed ID: 17167851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe hepatitis caused by cyproterone acetate.
    Blake JC; Sawyerr AM; Dooley JS; Scheuer PJ; McIntyre N
    Gut; 1990 May; 31(5):556-7. PubMed ID: 2140997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy of ursodeoxycholic acid and budesonide for PBC-AIH overlap syndrome: a meta-analysis.
    Zhang H; Yang J; Zhu R; Zheng Y; Zhou Y; Dai W; Wang F; Chen K; Li J; Wang C; Li S; Liu T; Abudumijiti H; Zhou Z; Wang J; Lu W; Wang J; Xia Y; Zhou Y; Lu J; Guo C
    Drug Des Devel Ther; 2015; 9():567-74. PubMed ID: 25632224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatotoxicity induced by cyproteron acetate in the prostate carcinoma treatment - a case report].
    Vodička M; Sálek T; Röderová E; Cerný D
    Klin Onkol; 2013; 26(1):47-8. PubMed ID: 23528173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Avascular necrosis of the femoral head in patients with prostate cancer treated with cyproterone acetate and radiotherapy.
    Macdonald AG; Bissett JD
    Clin Oncol (R Coll Radiol); 2001; 13(2):135-7. PubMed ID: 11373877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe hepatitis and liver failure induced by cyproterone acetate.
    Murphy BJ; Collins BJ
    Aust N Z J Med; 1996 Oct; 26(5):724. PubMed ID: 8958378
    [No Abstract]   [Full Text] [Related]  

  • 15. Budesonide or prednisone in combination with ursodeoxycholic acid in primary sclerosing cholangitis: a randomized double-blind pilot study. Belgian-Dutch PSC Study Group.
    van Hoogstraten HJ; Vleggaar FP; Boland GJ; van Steenbergen W; Griffioen P; Hop WC; van Hattum J; van Berge Henegouwen GP; Schalm SW; van Buuren HR
    Am J Gastroenterol; 2000 Aug; 95(8):2015-22. PubMed ID: 10950051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triple therapy for patients with primary biliary cirrhosis with progressive disease despite ursodeoxycholic acid: another step forward.
    Kaplan MM; Bonis PA
    Gastroenterol Clin Biol; 2010; 34(4-5):239-41. PubMed ID: 20462715
    [No Abstract]   [Full Text] [Related]  

  • 17. [Cholestatic acute hepatitis induced by amoxycillin-clavulanic acid combination. Role of ursodeoxycholic acid in drug-induced cholestasis].
    Barrio J; Castiella A; Lobo C; Indart A; López P; García-Bengoechea M; Cosme A; Arenas JI
    Rev Esp Enferm Dig; 1998 Jul; 90(7):523-6. PubMed ID: 9741209
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fatal subfulminant hepatitis caused by cyproterone acetate].
    Antoni M; Bourlière M; Toullec J; Maillot A; Botta-Fridlund D; Gauthier A
    Gastroenterol Clin Biol; 1991; 15(10):772-3. PubMed ID: 1840042
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyproterone acetate: hepatotoxicity and prostatic cancer treatment.
    Roila F; Crinò L; Carloni G; Natalini G
    Ann Oncol; 1993 Sep; 4(8):701. PubMed ID: 8241005
    [No Abstract]   [Full Text] [Related]  

  • 20. Reversal of cirrhosis in a patient with primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
    Vallone TM; Ditelberg J; Kaplan MM
    Dig Dis Sci; 2005 Jan; 50(1):167-70. PubMed ID: 15712656
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.